Piramal Pharma Limited (PPLPHARMA.BO)
INR 260.3
(-1.68%)
INR 260.3
(-1.68%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | 5.58 Billion | 4.83 Billion | 7.66 Billion | 347.2 Million |
| Net Income | 178.2 Million | -1.67 Billion | 4.41 Billion | 3.49 Billion |
| Depreciation & Amortization | 7.4 Billion | 6.76 Billion | 5.86 Billion | 609.6 Million |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 274.7 Million | - | - | - |
| Change in working capital | -2.41 Billion | -2.95 Billion | -2.92 Billion | -2.28 Billion |
| Other non-cash items | 20.4 Billion | 2.69 Billion | 315 Million | -1.47 Billion |
| Investing Cash Flow | -4.56 Billion | -13.38 Billion | -18.12 Billion | -43.82 Billion |
| Investments in PPE | -7.12 Billion | -9.64 Billion | -8.89 Billion | -581.1 Million |
| Acquisitions | 16 Million | -203.5 Million | -9.06 Billion | -37.75 Billion |
| Investment purchases | -16.9 Billion | -12.23 Billion | -15.33 Billion | - |
| Sales/Maturities of investments | 19.49 Billion | 8.34 Billion | 14.03 Billion | - |
| Other Investing Activities | -20.8 Million | 357 Million | 1.14 Billion | -5.49 Billion |
| Financing Cash Flow | 394.2 Million | 8.17 Billion | 7.94 Billion | 44.94 Billion |
| Debt repayment | -9.71 Billion | -31.86 Billion | -12.34 Billion | -3.83 Billion |
| Dividends payments | - | -670 Million | -500 Million | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 10.35 Billion | - | -1 Million | 42.33 Billion |
| Other Financing Activities | -5 Billion | 40.71 Billion | 20.78 Billion | 6.43 Billion |
| Accounts receivables | -3.91 Billion | 892.6 Million | -1.85 Billion | - |
| Accounts payables | 4.04 Billion | -2.64 Billion | 791.2 Million | - |
| Inventory | -5.31 Billion | -1.72 Billion | -1.75 Billion | 953.6 Million |
| Other working capital | 2.77 Billion | 529.5 Million | -106 Million | -3.23 Billion |
| Cash at beginning of period | 3.03 Billion | 851.8 Million | 2.61 Billion | 7.4 Million |
| Cash at end of period | 4.82 Billion | 532.3 Million | 851.8 Million | 1.46 Billion |
| Capital Expenditure | -7.12 Billion | -9.64 Billion | -8.89 Billion | -581.1 Million |
| Effect of forex changes on cash | 177.9 Million | 51.5 Million | -20.4 Million | - |
| Net cash flow / Change in cash | 1.78 Billion | -319.5 Million | -1.76 Billion | 1.45 Billion |
| Free Cash Flow | -1.54 Billion | -4.8 Billion | -1.23 Billion | -233.9 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 178.2 Million | 101.1 Million | 50.2 Million | -985.8 Million | -1.67 Billion | 501.1 Million |
| Depreciation & Amortization | 7.4 Billion | 1.86 Billion | 1.84 Billion | 1.73 Billion | 6.76 Billion | 1.84 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 274.7 Million | - | - | - | - | - |
| Change in working capital | -2.41 Billion | - | - | - | -2.95 Billion | - |
| Other non-cash items | 20.4 Billion | -1.86 Billion | -1.84 Billion | -1.73 Billion | 2.69 Billion | -1.84 Billion |
| Investing Cash Flow | -4.56 Billion | - | - | - | -13.38 Billion | - |
| Investments in PPE | -7.12 Billion | - | - | - | -9.64 Billion | - |
| Acquisitions | 16 Million | - | - | - | -203.5 Million | - |
| Investment purchases | -16.9 Billion | - | - | - | -12.23 Billion | - |
| Sales/Maturities of investments | 19.49 Billion | - | - | - | 8.34 Billion | - |
| Other Investing Activities | -20.8 Million | - | - | - | 357 Million | - |
| Financing Cash Flow | 394.2 Million | - | - | - | 8.17 Billion | - |
| Debt repayment | -9.71 Billion | - | - | - | -31.86 Billion | - |
| Dividends payments | - | - | - | - | -670 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.35 Billion | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 40.71 Billion | - |
| Accounts receivables | -3.91 Billion | - | - | - | 892.6 Million | - |
| Accounts payables | 4.04 Billion | - | - | - | -2.64 Billion | - |
| Inventory | -5.31 Billion | - | - | - | -1.72 Billion | - |
| Other working capital | 2.77 Billion | - | - | - | 529.5 Million | - |
| Cash at beginning of period | 3.03 Billion | 5.35 Billion | 5.3 Billion | 3.03 Billion | 851.8 Million | 2.53 Billion |
| Cash at end of period | 4.82 Billion | 101.1 Million | 5.35 Billion | -985.8 Million | 532.3 Million | 3.03 Billion |
| Capital Expenditure | -7.12 Billion | - | - | - | -9.64 Billion | - |
| Effect of forex changes on cash | 177.9 Million | - | - | - | 51.5 Million | - |
| Net cash flow / Change in cash | 1.78 Billion | -5.25 Billion | 50.2 Million | -4.02 Billion | -319.5 Million | 501.1 Million |
| Free Cash Flow | -1.54 Billion | 101.1 Million | 50.2 Million | -985.8 Million | -4.8 Billion | 501.1 Million |
ATAP
CBSM
MHKI
GOGL
OILRF
CORA